Skip to content 
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California. more
| Time Frame | HIMS | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 8.26% | -3.93% | -0.67% |
| 1-Month Return | -31.71% | -2.41% | -1.33% |
| 3-Month Return | -59.82% | 1.64% | -0.29% |
| 6-Month Return | -68.33% | 11.65% | 5.08% |
| 1-Year Return | -54.29% | 3.11% | 19.01% |
| 3-Year Return | 56.11% | 19.21% | 68.62% |
| 5-Year Return | 21.2% | 36.52% | 78.6% |
| 10-Year Return | 60.41% | 126.5% | 240.69% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 271.88M | 526.92M | 872.00M | 1.48B | 2.35B | [{"date":"2021-12-31","value":11.58,"profit":true},{"date":"2022-12-31","value":22.44,"profit":true},{"date":"2023-12-31","value":37.14,"profit":true},{"date":"2024-12-31","value":62.89,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 67.38M | 118.19M | 157.05M | 303.38M | 955.21M | [{"date":"2021-12-31","value":7.05,"profit":true},{"date":"2022-12-31","value":12.37,"profit":true},{"date":"2023-12-31","value":16.44,"profit":true},{"date":"2024-12-31","value":31.76,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 204.49M | 408.72M | 714.95M | 1.17B | 1.39B | [{"date":"2021-12-31","value":14.69,"profit":true},{"date":"2022-12-31","value":29.35,"profit":true},{"date":"2023-12-31","value":51.35,"profit":true},{"date":"2024-12-31","value":84.25,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Margin | 75.22% | 77.57% | 81.99% | 79.45% | 59.31% | [{"date":"2021-12-31","value":91.74,"profit":true},{"date":"2022-12-31","value":94.61,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.91,"profit":true},{"date":"2025-12-31","value":72.34,"profit":true}] |
| Operating Expenses | 319.54M | 477.42M | 744.40M | 1.11B | 1.27B | [{"date":"2021-12-31","value":25.15,"profit":true},{"date":"2022-12-31","value":37.57,"profit":true},{"date":"2023-12-31","value":58.58,"profit":true},{"date":"2024-12-31","value":87.45,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | (115.04M) | (68.70M) | (29.45M) | 61.90M | 121.69M | [{"date":"2021-12-31","value":-94.54,"profit":false},{"date":"2022-12-31","value":-56.45,"profit":false},{"date":"2023-12-31","value":-24.2,"profit":false},{"date":"2024-12-31","value":50.87,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | 4.25M | - | - | - | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | (110.80M) | (65.71M) | (21.57M) | 71.71M | 123.92M | [{"date":"2021-12-31","value":-89.41,"profit":false},{"date":"2022-12-31","value":-53.02,"profit":false},{"date":"2023-12-31","value":-17.41,"profit":false},{"date":"2024-12-31","value":57.87,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income Taxes | (3.14M) | (31.00K) | 1.98M | (54.33M) | (4.44M) | [{"date":"2021-12-31","value":-158.78,"profit":false},{"date":"2022-12-31","value":-1.57,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-2750.73,"profit":false},{"date":"2025-12-31","value":-224.86,"profit":false}] |
| Income After Taxes | (107.66M) | - | - | - | - | [{"date":"2021-12-31","value":-10765900000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | (107.66M) | (65.68M) | (23.55M) | 126.04M | 128.37M | [{"date":"2021-12-31","value":-83.87,"profit":false},{"date":"2022-12-31","value":-51.17,"profit":false},{"date":"2023-12-31","value":-18.34,"profit":false},{"date":"2024-12-31","value":98.19,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | (107.66M) | (65.68M) | (23.55M) | 126.04M | 128.37M | [{"date":"2021-12-31","value":-83.87,"profit":false},{"date":"2022-12-31","value":-51.17,"profit":false},{"date":"2023-12-31","value":-18.34,"profit":false},{"date":"2024-12-31","value":98.19,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| EPS (Diluted) | (0.56) | (0.32) | (0.11) | 0.54 | 0.51 | [{"date":"2021-12-31","value":-103.7,"profit":false},{"date":"2022-12-31","value":-59.26,"profit":false},{"date":"2023-12-31","value":-20.37,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":94.44,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| HIMS | |
|---|---|
| Cash Ratio | 1.43 |
| Current Ratio | 1.90 |
| Quick Ratio | 1.61 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| HIMS | |
|---|---|
| ROA (LTM) | 5.29% |
| ROE (LTM) | 25.23% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| HIMS | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.75 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.25 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| HIMS | |
|---|---|
| Trailing PE | 31.14 |
| Forward PE | 34.97 |
| P/S (TTM) | 1.54 |
| P/B | 6.93 |
| Price/FCF | 4409 |
| EV/R | 1.83 |
| EV/Ebitda | 26.81 |
| PEG | 1.83 |
Hims Hers Health Inc (HIMS) share price today is $15.74
Yes, Indians can buy shares of Hims Hers Health Inc (HIMS) on Vested. To buy
Yes, you can purchase fractional shares of Hims Hers Health Inc (HIMS) via the Vested app. You can start investing in Hims Hers Health Inc (HIMS) with a minimum investment of $1.
You can invest in shares of Hims Hers Health Inc (HIMS) via Vested in three simple steps:
The 52-week high price of Hims Hers Health Inc (HIMS) is $70.43. The 52-week low price of Hims Hers Health Inc (HIMS) is $13.74.
The price-to-earnings (P/E) ratio of Hims Hers Health Inc (HIMS) is 31.1373
The price-to-book (P/B) ratio of Hims Hers Health Inc (HIMS) is 6.93
The dividend yield of Hims Hers Health Inc (HIMS) is 0.00%
The market capitalization of Hims Hers Health Inc (HIMS) is $3.62B
The stock symbol (or ticker) of Hims Hers Health Inc is HIMS
Consider the share price of Hims Hers Health Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Hims Hers Health Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Hims Hers Health Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Hims Hers Health Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Hims Hers Health Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Hims Hers Health Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
